Clinical trial
Growth Hormone as Add-on Treatment in Severe Fibromyalgia With Low IGF-1 Serum…
NCT00497562 · Centro Medico Teknon, Other · Completed
Key facts
| NCT number | NCT00497562 |
|---|---|
| Title | Growth Hormone as Add-on Treatment in Severe Fibromyalgia With Low IGF-1 Serum Levels (56 Characters) |
| Official title | Exploratory Study to Investigate the Efficacy and Safety of Recombinant Growth Hormone as Add-on Treatment in Patients With Severe Fibromialgia |
| Lead sponsor | Centro Medico Teknon, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Fibromyalgia, Growth Hormone Deficiency |
| Intervention type | Drug |
| Interventions | sc recombinant growth hormone + amitriptyline, fluoxetine and tramadol (treated group), amitriptyline, fluoxetine and tramadol alone (control group) |
| Start date | May 1, 2004 |
| Completion | Nov 1, 2005 |
| First posted | Jul 6, 2007 |
| Last update posted | Jul 6, 2007 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: